Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis

Overview of attention for article published in Archives of Endocrinology and Metabolism, August 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Bisphosphonate Drugs for the Treatment of Osteoporosis in Post-Menopausal Women

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2021

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.